Cellebrite Announces Participation in Upcoming Investor Conferences
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 16, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2024
NEW YORK, April 26, 2024 /PRNewswire/ -- Average weekly trading volume of approximately 538,245 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience CLOSING
Analysts Have Conflicting Sentiments on These Technology Companies: Alkami Technology (ALKT), Cellebrite DI (CLBT) and Seagate Tech (STX)
Cellebrite DI Initiated at Buy by Lake Street
Cellebrite DI Initiated at Buy by Lake Street
Cellebrite DI (CLBT.US) was first covered by Lake Street, giving it a buying rating, with a target price of $13.00.
Cellebrite DI (CLBT.US) was first covered by Lake Street, giving it a buying rating, with a target price of $13.00.
Lake Street Initiates Coverage On Cellebrite DI With Buy Rating, Announces Price Target of $13
Lake Street analyst Frank Takkinen initiates coverage on Cellebrite DI with a Buy rating and announces Price Target of $13.
Cellebrite's Innovative C2C Platform and Strong Financials Merit Buy Rating
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?
Craig-Hallum Remains a Buy on Cellebrite DI (CLBT)
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it
Analysts Offer Insights on Technology Companies: Infinera (INFN) and Cellebrite DI (CLBT)
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?
Cellebrite DI Ltd. (NASDAQ:CLBT), might not be a large cap stock, but it saw a significant share price rise of 35% in the past couple of months on the NASDAQGS. Shareholders may appreciate the r
Cellebrite DI Is Maintained at Buy by Craig-Hallum
Cellebrite DI Is Maintained at Buy by Craig-Hallum
Cellebrite DI Price Target Raised to $16.00/Share From $14.00 by Craig-Hallum
Cellebrite DI Price Target Raised to $16.00/Share From $14.00 by Craig-Hallum
Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $16
Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to $16.
Analysts Offer Insights on Technology Companies: Semtech (SMTC), Coherent Corp (COHR) and Cellebrite DI (CLBT)
Cellebrite DI Is Maintained at Buy by B of A Securities
Cellebrite DI Is Maintained at Buy by B of A Securities
B of A Securities Maintains Buy on Cellebrite DI, Raises Price Target to $13
B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $12 to $13.
Cellebrite DI: A Strong Buy on Projected Growth and Platform Evolution
What Does Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price Indicate?
No Data